Sintana Energy secures time extension for Namibian offshore licence

Sintana Energy Inc

Sintana Energy has obtained a 12-month extension to its Petroleum Exploration Licence 87 offshore Namibia, giving its partners more time to advance exploration work before committing to drilling.

The decision removes immediate timing pressure on the licence and allows the joint venture to continue technical evaluation of the block. For investors, this keeps the asset active while delaying the need for near-term capital decisions tied to drilling.

Sintana’s interest in the licence is indirect, meaning its exposure depends on the pace and priorities of operating partners. The extension suggests those partners are not ready to move to drilling but still see sufficient potential to justify further work. This is typical in frontier basins, where additional seismic interpretation and subsurface analysis often precede final well planning.

The Namibian offshore sector has gained attention following nearby discoveries, which has increased interest across adjacent acreage. While this supports the perceived potential of Sintana’s position, it does not change the underlying exploration risk. No drilling commitment has yet been confirmed on this licence, and timelines remain dependent on partner alignment and technical results.

Sintana Energy Inc (TSX-V:SEI, OTCQX:SEUSF) is a public oil and natural gas exploration company listed on the Toronto Venture Exchange.

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search